FDA NDC Directory · JSON-LD · Markdown

Fosaprepitant

NDC 68001-675 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA209965
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsFOSAPREPITANT DIMEGLUMINE (150 mg/5mL)
Marketing started20251015
Package count1

External sources

Source: openFDA. Public-domain (CC0).